TY - JOUR
T1 - Coronary Venous Dissection from Left Ventricular Lead Placement During Cardiac Resynchronization Therapy With Defibrillator Implantation and Associated in-Hospital Adverse Events (from the NCDR ICD Registry)
AU - Hsu, Jonathan C.
AU - Varosy, Paul D.
AU - Bao, Haikun
AU - Dewland, Thomas A.
AU - Curtis, Jeptha P.
AU - Marcus, Gregory M.
N1 - Funding Information:
Funding sources: This research was supported by the American College of Cardiology Foundation's National Cardiovascular Data Registry (NCDR). The views expressed in this manuscript represent those of the authors, and do not necessarily represent the official views of the NCDR or its associated professional societies identified at www.ncdr.com . The ICD Registry is an initiative of the American College of Cardiology Foundation and the Heart Rhythm Society.
Funding Information:
The NCDR ICD registry was created in 2006 to meet the requirements of the Centers for Medicare & Medicaid Services' Coverage with Evidence Development decision. 6 The Heart Rhythm Society and American College of Cardiology collaborated to establish a national registry of ICD implantations, funded by a combination of hospital fees and grants from payers and device companies. Hospitals are mandated to provide data on Medicare beneficiaries receiving an ICD for primary prevention of sudden cardiac death; however, 71.5% of the 1,375 participating hospitals are providing data on all patients undergoing ICD implantation (including CRT-D implantations), and these hospitals submit 88.4% of all ICD implants included in the registry. 6 This study included all eligible patients enrolled in the NCDR ICD Registry between January, 2006 and September, 2011 which included Versions 1.0 and 2.0 data that had been subjected to accuracy data review. NCDR ICD Registry data have undergone data quality standard testing, including an auditing program to confirm completeness and verify greater than 91% raw accuracy of data abstraction, as previously detailed. 6–8
Publisher Copyright:
© 2017 Elsevier Inc.
PY - 2018/1/1
Y1 - 2018/1/1
N2 - Coronary venous dissection is a known complication of left ventricular lead placement during implantation of a cardiac resynchronization with defibrillator (CRT-D) system. A large-scale evaluation of the prevalence of coronary venous dissection and associated in-hospital clinical outcomes has not been performed. We sought to identify predictors of coronary venous dissection and evaluate subsequent in-hospital adverse events in those with the complication. We studied 140,991 first-time CRT-D recipients in the implantable cardioverter-defibrillator (ICD) Registry implanted between 2006 and 2011. Using hierarchical multivariable logistic regression adjusting for patient, implanting physician, and hospital characteristics, we examined predictors of coronary venous dissection and its association with other major complications, length of hospital stay, and in-hospital mortality. Coronary venous dissection occurred in 392 patients (0.28%). After multivariable adjustment, female gender and left bundle branch block were associated with greater odds of coronary venous dissection. Conversely, atrial fibrillation, previous coronary artery bypass graft, and higher implanter procedure volume were associated with lower odds of coronary venous dissection (all p values <0.05). After multivariable adjustment, CRT-D recipients with coronary venous dissection had greater odds of major complications (odds ratio [OR] 10.47, 95% confidence interval [CI] 6.75 to 16.24, p <0.0001), postprocedural hospital stays >3 days (OR 1.71, 95% CI 1.29 to 2.29, p <0.0001), but not in-hospital death (OR 0.78, 95% CI 0.12 to 5.25, p = 0.8012). In conclusion, in a large population of first-time CRT-D recipients, specific patient and implanter characteristics predicted coronary venous dissection risk. Coronary venous dissection was associated with major in-hospital complications and prolonged hospitalization, but not death.
AB - Coronary venous dissection is a known complication of left ventricular lead placement during implantation of a cardiac resynchronization with defibrillator (CRT-D) system. A large-scale evaluation of the prevalence of coronary venous dissection and associated in-hospital clinical outcomes has not been performed. We sought to identify predictors of coronary venous dissection and evaluate subsequent in-hospital adverse events in those with the complication. We studied 140,991 first-time CRT-D recipients in the implantable cardioverter-defibrillator (ICD) Registry implanted between 2006 and 2011. Using hierarchical multivariable logistic regression adjusting for patient, implanting physician, and hospital characteristics, we examined predictors of coronary venous dissection and its association with other major complications, length of hospital stay, and in-hospital mortality. Coronary venous dissection occurred in 392 patients (0.28%). After multivariable adjustment, female gender and left bundle branch block were associated with greater odds of coronary venous dissection. Conversely, atrial fibrillation, previous coronary artery bypass graft, and higher implanter procedure volume were associated with lower odds of coronary venous dissection (all p values <0.05). After multivariable adjustment, CRT-D recipients with coronary venous dissection had greater odds of major complications (odds ratio [OR] 10.47, 95% confidence interval [CI] 6.75 to 16.24, p <0.0001), postprocedural hospital stays >3 days (OR 1.71, 95% CI 1.29 to 2.29, p <0.0001), but not in-hospital death (OR 0.78, 95% CI 0.12 to 5.25, p = 0.8012). In conclusion, in a large population of first-time CRT-D recipients, specific patient and implanter characteristics predicted coronary venous dissection risk. Coronary venous dissection was associated with major in-hospital complications and prolonged hospitalization, but not death.
UR - http://www.scopus.com/inward/record.url?scp=85032929244&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85032929244&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2017.09.019
DO - 10.1016/j.amjcard.2017.09.019
M3 - Article
C2 - 29102348
AN - SCOPUS:85032929244
SN - 0002-9149
VL - 121
SP - 55
EP - 61
JO - American Journal of Cardiology
JF - American Journal of Cardiology
IS - 1
ER -